Objective To investigate the feasibility and effect of human amniotic membrane in prevention of tendon adhension after tendon sheat defect repair. Methods The amniotic membrane in size of 1.5 cm × 1.0 cm was harvested from human placenta which was voluntary donated from maternal after cesarean. Forty healthy male Leghorn chicken (aged 3-6 months) were selected, weighing (1.86 ± 0.04) kg. The model of flexor digitorum profundus tendon and tendon sheath defects was established at the third toe. After repair of the flexor digitorum profundus tendon, the human amniotic membrane was used to repair the tendon sheath defect in the right foot (group A), but tendon sheath defect was not repaired in the left foot (group B) . At 1, 2, 4, and 6 weeks after operation, the gross and histological observations were done; the degree of tendon adhesions was graded according to Tang’s tendon adhesion general observation grading standards; and the biomechanical properties (tendon slip length and total flexion angle) were tested. Results All animals survived after operation and incisions healed. Gross and histological observations showed that the new tendon sheath formed with time passing after operation in groups A and B; new tendon sheath was more maturer and smoother in group A than in group B. The degree of tendon adhesions in group A was significantly less than that in group B (P lt; 0.05) at 1 and 6 weeks after operation. The biomechanical test results showed there was no significant difference in the tendon slip length between 2 groups at 1 and 2 weeks after operation (P gt; 0.05), but the tendon slip length of group A was significantly longer than that of group B at 4 and 6 weeks after operation (P lt; 0.05). The total flexion angle of group A was significantly smaller than that of group B at 1, 2, 4, and 6 weeks after operation (P lt; 0.05). Conclusion It is effective in the prevention of tendon adhesion to use the amniotic membrane for repairing the tendon sheath defect, which is beneficial to recovery of the tendon sliding function.
ObjectiveTo systematically review the efficacy of pulse indicating continuous cardiac output (PICCO) monitoring for guiding the treatment of patients with septic shock.MethodsDatabases including PubMed, The Cochrane Library, EMbase, Web of Science, CBM, WanFang Data, VIP and CNKI were electronically searched from inception to February 2017 to collect randomized controlled trials (RCTs) about PICCO monitoring on treatment guidance of patients with septic shock. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies. Then meta-analysis was performed using Stata 12.0 software.ResultsA total of 20 RCTs involving 1 253 patients were included. The results of meta-analysis showed: compared with central venous pressure (CVP) measurements, the treatment of sepsis bundles informed by PICCO could significantly shorten the length of intensive care unit (ICU) stay (MD=–2.74, 95%CI –3.40 to –2.09, P<0.001), reduce the ICU mortality (RR=0.49, 95%CI 0.36 to 0.67, P<0.001) and 28-day mortality (RR=0.61, 95%CI 0.43 to 0.87, P=0.006).ConclusionCurrent evidence shows the PICCO monitoring can significantly improve the prognosis of septic shock. Due to limited and quantity quality of the included studies, more high-quality studies are needed to verify above conclusion.